2008 News Archive
Please browse our press releases below. These are all
in Adobe Acrobat PDF format. If you do not have an appropriate PDF
reader, please click here
ProStrakan Announces Outlicensing of Abstral and Sancuso in Canada
22nd December 2008
Abstral Receives Marketing Approval in Germany
11th December 2008
ProStrakan and Bayer Schering Pharma Partner to Develop Tostran in 65 Territories Worldwide
27th November 2008
ProStrakan Announces NewBridge Pharmaceuticals as Partner for Sancuso in the Middle East and Africa
6th November 2008
ProStrakan Receives US FDA Approval for Sancuso
15th September 2008
Interim Results for the Six Months Ended 30 June 2008
21st August 2008
ProStrakan and Orexo Extend Licensing Agreement for Rapinyl/Abstral to include North America
31st July 2008
Testosterone replacement study shows positive results in diabetic men from 2% testosterone gel
18th June 2008
ProStrakan and JapanBridge Partner to Develop Sancuso in Japan, China & Parts of SE Asia
23rd May 2008
Result of resolutions passed at Annual General Meeting
21st May 2008
ProStrakan announces Torrex Chiesi as partner for Xomolix in Austria and CEE
19th May 2008
ProStrakan announces positive results from pivotal US "Fortify" study on Fortigel (testosterone 2% gel)
8th May 2008
Xomolix Receives Additional Key European Approvals
2nd April 2008
ProStrakan Reports Further Progress in a Year of Significant Developments
13th March 2008
Rapinyl Receives Swedish Marketing Authorisation
7th March 2008
ProStrakan Reports Further Strong Progress in Pre-Close Update
